Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Ramirez

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biologyJohn W Adams, Juan Ramirez, Yunqing Shi, et al.
Frontiers in Immunology|January 10, 2018
Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life ImmunizationFrancesco Borriello, Carlo Pietrasanta, Jacqueline C Y Lai, et al.
Journal of Cardiovascular Computed Tomography|August 23, 2023
AI-based, automated chamber volumetry from gated, non-contrast CTAthira J Jacob, Ola Abdelkarim, Salma Zook, et al.
Vaccine|November 28, 2018
Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitroAnne Marie Queenan, David J Dowling, Wing Ki Cheng, et al.
BMJ Open|November 20, 2025
Effect of music therapy on vital signs and heart rate variability of paediatric patients during the extubation process in the paediatric intensive care unit: a multicentre randomised clinical trial protocolYenny Marcela Beltrán, Daniela Posada Charum, Cesar Augusto Zuluaga, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2015
Discovery of a new series of potent prostacyclin receptor agonists with in vivo activity in ratThuy-Anh Tran, Young-Jun Shin, Bryan Kramer, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agentsPeter I Dosa, Sonja Strah-Pleynet, Honnappa Jayakumar, et al.
European Urology Oncology|October 31, 2025
Classification of Inaccurate Information About Prostate Cancer on Social Media in English and SpanishStacy Loeb, Mariana Rangel Camacho, Tatiana Sanchez Nolasco, et al.
Journal of Medicinal Chemistry|January 11, 2017
Discovery of 2-(((1r,4r)-4-(((4-Chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (Ralinepag): An Orally Active Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial HypertensionThuy-Anh Tran, Bryan Kramer, Young-Jun Shin, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biologyJohn W Adams, Juan Ramirez, Yunqing Shi, et al.
Frontiers in Immunology|January 10, 2018
Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life ImmunizationFrancesco Borriello, Carlo Pietrasanta, Jacqueline C Y Lai, et al.
Journal of Cardiovascular Computed Tomography|August 23, 2023
AI-based, automated chamber volumetry from gated, non-contrast CTAthira J Jacob, Ola Abdelkarim, Salma Zook, et al.
Vaccine|November 28, 2018
Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitroAnne Marie Queenan, David J Dowling, Wing Ki Cheng, et al.
BMJ Open|November 20, 2025
Effect of music therapy on vital signs and heart rate variability of paediatric patients during the extubation process in the paediatric intensive care unit: a multicentre randomised clinical trial protocolYenny Marcela Beltrán, Daniela Posada Charum, Cesar Augusto Zuluaga, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2015
Discovery of a new series of potent prostacyclin receptor agonists with in vivo activity in ratThuy-Anh Tran, Young-Jun Shin, Bryan Kramer, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agentsPeter I Dosa, Sonja Strah-Pleynet, Honnappa Jayakumar, et al.
European Urology Oncology|October 31, 2025
Classification of Inaccurate Information About Prostate Cancer on Social Media in English and SpanishStacy Loeb, Mariana Rangel Camacho, Tatiana Sanchez Nolasco, et al.
Journal of Medicinal Chemistry|January 11, 2017
Discovery of 2-(((1r,4r)-4-(((4-Chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (Ralinepag): An Orally Active Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial HypertensionThuy-Anh Tran, Bryan Kramer, Young-Jun Shin, et al.
Pageof 6